Blackrock, INC Schedule 13G passive stakes
NYSE
BlackRock, Inc. has filed an Amendment No. 6 to its Schedule 13G, disclosing a 2.1% passive beneficial ownership stake in Cardlytics, Inc. as of June 30, 2025.
NYSE
BlackRock, Inc. has filed an amendment to its Schedule 13G, disclosing a 3.2% passive beneficial ownership stake in Cassava Sciences Inc. as of June 30, 2025.
NYSE
BlackRock, Inc. has filed an amendment to its Schedule 13G, disclosing a continued beneficial ownership of 8.8% of Chewy, Inc.'s common stock as of June 30, 2025.
NYSE
BlackRock, Inc. has filed an updated Schedule 13G, revealing a 1.3% passive beneficial ownership stake in Clear Channel Outdoor Holdings Inc. as of June 30, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 6.9% Stake in Coinbase Class A Stock
BlackRock, Inc. has filed an amended Schedule 13G, revealing a beneficial ownership of 6.9% of Coinbase Global Inc.'s Class A stock.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 1.8% Passive Stake in Shattuck Labs
BlackRock, Inc. has filed an amended Schedule 13G, reporting a passive beneficial ownership of 1.8% of Shattuck Labs, Inc.'s common stock as of June 30, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 1.6% Passive Stake in SmartRent, Inc.
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 1.6% beneficial ownership stake in SmartRent, Inc.'s common stock as of June 30, 2025.
NYSE
BlackRock, Inc. has filed an amendment to its Schedule 13G, disclosing a 2.9% beneficial ownership stake in Stagwell Inc. as of June 30, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 2.8% Passive Stake in Star Holdings
BlackRock, Inc. has filed an amended Schedule 13G, reporting a passive beneficial ownership of 2.8% in Star Holdings' common stock as of June 30, 2025.
NYSE
BlackRock, Inc. has filed an amendment to its Schedule 13G, reporting a passive beneficial ownership of 2.3% in Stoneridge Inc.'s common stock as of June 30, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Reduces Stake in TPI Composites Below 5%
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a beneficial ownership of 1.8% in TPI Composites Inc. common stock.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 1.7% Stake in Tenaya Therapeutics
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 1.7% beneficial ownership stake in Tenaya Therapeutics, Inc. as of June 30, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 7.6% Stake in 10x Genomics
BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 7.6% of the common stock of 10x Genomics, Inc. as of June 30, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 1.9% Passive Stake in Ventyx Biosciences
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 1.9% passive beneficial ownership stake in Ventyx Biosciences, Inc. as of June 30, 2025.
NYSE
BlackRock, Inc. has filed an amendment to its Schedule 13G, disclosing a 1.7% beneficial ownership stake in Vera Bradley Inc. as of a future event date of June 30, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 7.8% Stake in Verisk Analytics
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 7.8% beneficial ownership stake in Verisk Analytics, Inc. as of June 30, 2025.
NYSE
BlackRock, Inc. has filed an amendment to its Schedule 13G, disclosing a passive ownership of 1.1% of VERU INC's common stock as of June 30, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 3 to its Schedule 13G, disclosing a 1.4% beneficial ownership stake in Virgin Galactic Holdings, Inc. as of June 30, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 6.9% Stake in Yext, Inc. Common Stock
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 6.9% beneficial ownership stake in Yext, Inc.'s common stock as of June 30, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 0.6% Passive Stake in Achieve Life Sciences
BlackRock, Inc. has filed an amended Schedule 13G, reporting a passive beneficial ownership of 0.6% of Achieve Life Sciences Inc.'s common stock as of June 30, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 5.3% Passive Stake in Alico, Inc.
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 5.3% beneficial ownership stake in Alico, Inc.'s common stock, held in the ordinary course of business.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 5.6% of Atlanta Braves Holdings, Inc. common stock as of June 30, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Trims Stake in Byline Bancorp to 4.6%
BlackRock, Inc. has filed an amendment to its Schedule 13G, disclosing a reduced beneficial ownership of 4.6% in Byline Bancorp, Inc.'s common stock.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 6.3% Stake in CECO Environmental Corp.
BlackRock, Inc. has filed an amended Schedule 13G, reporting beneficial ownership of 6.3% of CECO Environmental Corp.'s common stock as of June 30, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Amends Passive Stake in Caribou Biosciences
BlackRock, Inc. has filed an amendment to its Schedule 13G, disclosing a 2.0% passive ownership stake in Caribou Biosciences, Inc. as of June 30, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 2.1% Passive Stake in Chegg Inc.
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 2.1% passive beneficial ownership stake in Chegg Inc. as of June 30, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 1.5% Stake in Commercial Vehicle Group Inc.
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 1.5% beneficial ownership stake in Commercial Vehicle Group Inc.'s common stock.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 6.9% beneficial ownership stake in Conduent Inc.'s common stock.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 7.5% passive beneficial ownership stake in Cross Country Healthcare Inc.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 6.0% beneficial ownership stake in A. O. Smith Corp.'s common stock as of June 30, 2025.